Have a personal or library account? Click to login
Abuse Liability Assessment of the RELX Infinity® Electronic Nicotine Delivery System Among Adult Smokers and Electronic Nicotine Delivery System Users Cover

Abuse Liability Assessment of the RELX Infinity® Electronic Nicotine Delivery System Among Adult Smokers and Electronic Nicotine Delivery System Users

Open Access
|Jul 2025

References

  1. Breland, A., E. Soule, A. Lopez, C. Ramôa, A. El-Hellani, and T. Eissenberg: Electronic Cigarettes: What Are They and What Do They Do?; Ann. N.Y. Acad. Sci. 1394 (2017) 5–30. DOI: 10.1111/nyas.12977.
  2. 2. Zimmermann, R., R. Hertz-Schünemann, S. Ehlert, C. Liu, K. McAdam, R. Baker, and T. Streibel: Highly Time-Resolved Imaging of Combustion and Pyrolysis Product Concentrations in Solid Fuel Combustion: NO Formation in a Burning Cigarette; Anal. Chem. 87 (2015) 1711–1717. DOI: 10.1021/ac503512a
    Zimmermann R. Hertz-Schünemann R. Ehlert S. Liu C. McAdam K. Baker R. Streibel T. Highly Time-Resolved Imaging of Combustion and Pyrolysis Product Concentrations in Solid Fuel Combustion: NO Formation in a Burning Cigarette Anal. Chem. 87 2015 1711 1717 10.1021/ac503512a
  3. 3. Perfetti, T.A. and A. Rodgman: The Complexity of Tobacco and Tobacco Smoke; Beitr. Tabakforsch. Int. 24 (2011) 215–232. DOI: 10.2478/cttr-2013-0902
    Perfetti T.A. Rodgman A. The Complexity of Tobacco and Tobacco Smoke Beitr. Tabakforsch. Int. 24 2011 215 232 10.2478/cttr-2013-0902
  4. 4. Margham, J., K. McAdam, M. Forster, C. Liu, C. Wright, D. Mariner, and C. Proctor: Chemical Composition of Aerosol from an E-Cigarette: A Quantitative Comparison with Cigarette Smoke; Chem. Res. Toxicol. 29 (2016) 1662–1678. DOI: 10.1021/acs.chemrestox.6b00188
    Margham J. McAdam K. Forster M. Liu C. Wright C. Mariner D. Proctor C. Chemical Composition of Aerosol from an E-Cigarette: A Quantitative Comparison with Cigarette Smoke Chem. Res. Toxicol. 29 2016 1662 1678 10.1021/acs.chemrestox.6b00188
  5. 5. National Academies of Sciences Engineering and Medicine: Public Health Consequences of E-Cigarettes; edited by K. Stratton, L.Y. Kwan, and D.L. Eaton, National Academies Press, Washington, DC, USA, 2018, 680 pp. DOI: 10.17226/24952
    National Academies of Sciences Engineering and Medicine Public Health Consequences of E-Cigarettes Stratton K. Kwan L.Y. Eaton D.L. National Academies Press Washington, DC, USA 2018 680 10.17226/24952
  6. McNeill, A., L.S. Brose, R. Calder, L. Bauld, and D. Robson: Evidence Review of E-Cigarettes and Heated Tobacco Products 2018. A Report Commissioned by Public Health England; Public Health England, London, UK, 2018. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/684963/Evidence_review_of_ecigarettes_and_heated_tobacco_products_2018.pdf (accessed June 11, 2025).
  7. 7. Shahab, L., M.L. Goniewicz, B.C. Blount, J. Brown, A. McNeill, K.U. Alwis, J. Feng, L. Wang, and R. West: Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-Sectional Study; Ann. Intern. Med. 166 (2017) 390–400. DOI: 10.7326/M16-1107
    Shahab L. Goniewicz M.L. Blount B.C. Brown J. McNeill A. Alwis K.U. Feng J. Wang L. West R. Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-Sectional Study Ann. Intern. Med. 166 2017 390 400 10.7326/M16-1107
  8. 8. Goniewicz, M.L., D.M. Smith, K.C. Edwards, B.C. Blount, K.L. Caldwell, J. Feng, L. Wang, C. Christensen, B. Ambrose, N. Borek, D. van Bemmel, K. Konkel, G. Erives, C.A. Stanton, E. Lambert, H.L. Kimmel, D. Hatsukami, S.S. Hecht, R.S. Niaura, M. Travers, et al.: Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes; JAMA Network Open 1 (2018) e185937. DOI: 10.1001/jamanetworkopen.2018.5937
    Goniewicz M.L. Smith D.M. Edwards K.C. Blount B.C. Caldwell K.L. Feng J. Wang L. Christensen C. Ambrose B. Borek N. van Bemmel D. Konkel K. Erives G. Stanton C.A. Lambert E. Kimmel H.L. Hatsukami D. Hecht S.S. Niaura R.S. Travers M. Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes JAMA Network Open 1 2018 e185937 10.1001/jamanetworkopen.2018.5937
  9. 9. Smith, D.M., L. Shahab, B.C. Blount, M. Gawron, L. Kosminder, A. Sobczak, B. Xia, C.S. Sosnoff, and M.L. Goniewicz: Differences in Exposure to Nicotine, Tobacco-Specific Nitrosamines, and Volatile Organic Compounds among Electronic Cigarette Users, Tobacco Smokers, and Dual Users from Three Countries; Toxics 8 (2020) 88. DOI: 10.3390/toxics8040088
    Smith D.M. Shahab L. Blount B.C. Gawron M. Kosminder L. Sobczak A. Xia B. Sosnoff C.S. Goniewicz M.L. Differences in Exposure to Nicotine, Tobacco-Specific Nitrosamines, and Volatile Organic Compounds among Electronic Cigarette Users, Tobacco Smokers, and Dual Users from Three Countries Toxics 8 2020 88 10.3390/toxics8040088
  10. 10. Cohen, G., N.I. Goldenson, P. Bailey, S. Chan, and S. Shiffman: Changes in Biomarkers of Cigarette Smoke Exposure After 6 Days of Switching Exclusively or Partially to Use of the JUUL System With Two Nicotine Concentrations: A Randomized Controlled Confinement Study in Adult Smokers; Nicotine Tob. Res. 23 (2021) 2153–2161. DOI: 10.1093/ntr/ntab134
    Cohen G. Goldenson N.I. Bailey P. Chan S. Shiffman S. Changes in Biomarkers of Cigarette Smoke Exposure After 6 Days of Switching Exclusively or Partially to Use of the JUUL System With Two Nicotine Concentrations: A Randomized Controlled Confinement Study in Adult Smokers Nicotine Tob. Res. 23 2021 2153 2161 10.1093/ntr/ntab134
  11. 11. McEwan, M., N. Gale, J.K. Ebajemito, O.M. Camacho, G. Hardie, C.J. Proctor, and J. Murphy: A Randomized Controlled Study in Healthy Participants to Explore the Exposure Continuum When Smokers Switch to a Tobacco Heating Product or an E-Cigarette Relative to Cessation; Toxicol. Rep. 8 (2021) 994–1001. DOI: 10.1016/j.toxrep.2021.05.003
    McEwan M. Gale N. Ebajemito J.K. Camacho O.M. Hardie G. Proctor C.J. Murphy J. A Randomized Controlled Study in Healthy Participants to Explore the Exposure Continuum When Smokers Switch to a Tobacco Heating Product or an E-Cigarette Relative to Cessation Toxicol. Rep. 8 2021 994 1001 10.1016/j.toxrep.2021.05.003
  12. 12. Morris P., S. McDermott, F. Chapman, T. Verron, X. Cahours, M. Stevenson, J. Thompson, N. Chaudhary, and G. O’Connell: Reductions in Biomarkers of Exposure to Selected Harmful and Potentially Harmful Constituents Following Exclusive and Partial Switching from Combustible Cigarettes to Myblu™ Electronic Nicotine Delivery Systems (ENDS). Intern. Emerg. Med. 17 (2022) 397–410. DOI: 10.1007/s11739-021-02813-w
    Morris P. McDermott S. Chapman F. Verron T. Cahours X. Stevenson M. Thompson J. Chaudhary N. O’Connell G. Reductions in Biomarkers of Exposure to Selected Harmful and Potentially Harmful Constituents Following Exclusive and Partial Switching from Combustible Cigarettes to Myblu™ Electronic Nicotine Delivery Systems (ENDS) Intern. Emerg. Med. 17 2022 397 410 10.1007/s11739-021-02813-w
  13. 13. Koh, H.K. and M.C. Fiore: The Tobacco Industry and Harm Reduction; JAMA 328 (2022) 2009–2010. DOI: 10.1001/jama.2022.20679
    Koh H.K. Fiore M.C. The Tobacco Industry and Harm Reduction JAMA 328 2022 2009 2010 10.1001/jama.2022.20679
  14. 14. Abrams, D.B., A.M. Glasser, A.C. Villanti, J.L. Pearson, S. Rose, and R.S. Niaura: Managing Nicotine Without Smoke to Save Lives Now: Evidence for Harm Minimization; Prev. Med. 117 (2018) 88–97. DOI: 10.1016/j.ypmed.2018.06.010
    Abrams D.B. Glasser A.M. Villanti A.C. Pearson J.L. Rose S. Niaura R.S. Managing Nicotine Without Smoke to Save Lives Now: Evidence for Harm Minimization Prev. Med. 117 2018 88 97 10.1016/j.ypmed.2018.06.010
  15. 15. Levy, D.T., R. Borland, E.N. Lindblom, M.L. Goniewicz, R. Meza, T.R. Holford, Z. Yuan, Y. Luo, R.J. O’Connor, R. Niaura, and D.B. Abrams: Potential Deaths Averted in USA by Replacing Cigarettes with E-Cigarettes; Tob. Control 27 (2018) 18–25. DOI: 10.1136/tobaccocontrol-2017-053759
    Levy D.T. Borland R. Lindblom E.N. Goniewicz M.L. Meza R. Holford T.R. Yuan Z. Luo Y. O’Connor R.J. Niaura R. Abrams D.B. Potential Deaths Averted in USA by Replacing Cigarettes with E-Cigarettes Tob. Control 27 2018 18 25 10.1136/tobaccocontrol-2017-053759
  16. New Zealand Ministry of Health: Website - “Vaping Facts”; Health New Zealand, Wellington, New Zealand, 2022. Available at: https://vapingfacts.health.nz/our-position-on-vaping.html (accessed June 24, 2025)
  17. Government of Canada, Health Canada: Website – “Vaping and Quitting Smoking”; Health Canada, Ottawa, ON, Canada, 2022, last updated February 17, 2023. Available at: www.canada.ca/en/health-canada/services/smoking-tobacco/vaping/smokers.html (accessed June 11, 2025)
  18. McNeill, A., E. Simonavicius, L. Brose, E. Taylor, K. East, E. Zuikova, R. Calder, and D. Robson: Nicotine Vaping in England: An Evidence Update Including Health Risks and Perceptions, 2022. A Report Commissioned by the Office for Health Improvement and Disparities; Office for Health Improvement and Disparities, London, UK, September 29, 2022. Available at: https://assets.publishing.service.gov.uk/media/633469fc8fa8f5066d28e1a2/Nicotine-vaping-in-England-2022-report.pdf (accessed June 11, 2025)
  19. 19. Zhu, S.H., Y.L. Zhuang, S. Wong, S.E. Cummins, and G.J. Tedeschi: E-Cigarette Use and Associated Changes in Population Smoking Cessation: Evidence from US Current Population Surveys; BMJ 358 (2017) j3262. DOI: 10.1136/bmj.j3262
    Zhu S.H. Zhuang Y.L. Wong S. Cummins S.E. Tedeschi G.J. E-Cigarette Use and Associated Changes in Population Smoking Cessation: Evidence from US Current Population Surveys BMJ 358 2017 j3262 10.1136/bmj.j3262
  20. 20. Giovenco, D.P. and C.D. Delnevo: Prevalence of Population Smoking Cessation by Electronic Cigarette Use Status in a National Sample of Recent Smokers; Addict. Behav. 76 (2018) 129–134. DOI: 10.1016/j.addbeh.2017.08.002
    Giovenco D.P. Delnevo C.D. Prevalence of Population Smoking Cessation by Electronic Cigarette Use Status in a National Sample of Recent Smokers Addict. Behav. 76 2018 129 134 10.1016/j.addbeh.2017.08.002
  21. 21. Levy, D.T., Z. Yuan, Y. Luo, and D.B. Abrams: The Relationship of E-Cigarette Use to Cigarette Quit Attempts and Cessation: Insights from a Large, Nationally Representative U.S. Survey; Nicotine Tob. Res. 20 (2018) 931–939. DOI: 10.1093/ntr/ntx166
    Levy D.T. Yuan Z. Luo Y. Abrams D.B. The Relationship of E-Cigarette Use to Cigarette Quit Attempts and Cessation: Insights from a Large, Nationally Representative U.S. Survey Nicotine Tob. Res. 20 2018 931 939 10.1093/ntr/ntx166
  22. 22. Berry, K.M., L.M. Reynolds, J.M. Collins, M.B. Siegel, J.L. Fetterman, N.M. Hamburg, A. Bhatnagar, E.J. Benjamin, and A. Stokes: E-Cigarette Initiation and Associated Changes in Smoking Cessation and Reduction: The Population Assessment of Tobacco and Health Study, 2013–2015. Tob. Control 28 (2019) 42–49. DOI: 10.1136/tobaccocontrol-2017-054108
    Berry K.M. Reynolds L.M. Collins J.M. Siegel M.B. Fetterman J.L. Hamburg N.M. Bhatnagar A. Benjamin E.J. Stokes A. E-Cigarette Initiation and Associated Changes in Smoking Cessation and Reduction: The Population Assessment of Tobacco and Health Study, 2013–2015. Tob Control 28 2019 42 49 10.1136/tobaccocontrol-2017-054108
  23. 23. Beard E., R. West, S. Michie, and J. Brown: Association of Prevalence of Electronic Cigarette Use with Smoking Cessation and Cigarette Consumption in England: A Time-Series Analysis Between 2006 and 2017; Addiction 115 (2020) 961–974. DOI: 10.1111/add.14851
    Beard E. West R. Michie S. Brown J. Association of Prevalence of Electronic Cigarette Use with Smoking Cessation and Cigarette Consumption in England: A Time-Series Analysis Between 2006 and 2017 Addiction 115 2020 961 974 10.1111/add.14851
  24. 24. Pierce, J.P., T. Benmarhnia, R. Chen, M. White, D.B. Abrams, B.K. Ambrose, C. Blanco, N. Borek, K. Choi, B. Coleman, W.M. Compton, K.M. Cummings, C.D. Delnevo, T. Elton-Marshall, M.L. Goniewicz, S. Gravely, G.T. Fong, D. Hatsukami, J. Henrie, K.A. Kasza, et al.: Role of E-Cigarettes and Pharmacotherapy During Attempts to Quit Cigarette Smoking: The PATH Study 2013–16; PLoS ONE 15 (2020) e0237938. DOI: 10.1371/journal.pone.0237938
    Pierce J.P. Benmarhnia T. Chen R. White M. Abrams D.B. Ambrose B.K. Blanco C. Borek N. Choi K. Coleman B. Compton W.M. Cummings K.M. Delnevo C.D. Elton-Marshall T. Goniewicz M.L. Gravely S. Fong G.T. Hatsukami D. Henrie J. Kasza K.A. Role of E-Cigarettes and Pharmacotherapy During Attempts to Quit Cigarette Smoking: The PATH Study 2013–16 PLoS ONE 15 2020 e0237938 10.1371/journal.pone.0237938
  25. 25. Hartmann-Boyce, J., N. Lindson, A.R. Butler, H. McRobbie, C. Bullen, R. Begh, A. Theodoulou, C. Notley, N.A. Rigotti, T. Turner, T.R. Fanshawe, and P. Hajek: Electronic Cigarettes for Smoking Cessation; Cochrane Database Syst Rev. 11 (2022) Cd010216. DOI: 10.1002/14651858.CD010216.pub7
    Hartmann-Boyce J. Lindson N. Butler A.R. McRobbie H. Bullen C. Begh R. Theodoulou A. Notley C. Rigotti N.A. Turner T. Fanshawe T.R. Hajek P. Electronic Cigarettes for Smoking Cessation Cochrane Database Syst Rev. 11 2022 Cd010216 10.1002/14651858.CD010216.pub7
  26. 26. Fagerström, K.: Can Alternative Nicotine Products Put the Final Nail in the Smoking Coffin?; Harm. Reduct. J. 19 (2022) 131. DOI: 10.1186/s12954-022-00722-5
    Fagerström K. Can Alternative Nicotine Products Put the Final Nail in the Smoking Coffin? Harm. Reduct. J. 19 2022 131 10.1186/s12954-022-00722-5
  27. 27. Fearon I.M. Human Abuse Liability Assessment of E-Cigarettes: Why, What and How? Drug Test. Anal. 15 (2022) 1211–1221. DOI: 10.1002/dta.3251
    Fearon I.M. Human Abuse Liability Assessment of E-Cigarettes: Why, What and How? Drug Test. Anal. 15 2022 1211 1221 10.1002/dta.3251
  28. U.S. Department of Health and Human Services (DHHS), U.S. Food and Drug Administration (FDA), Center for Tobacco Products (CPT): Premarket Tobacco Product Applications for Electronic Nicotine Delivery Systems (Revised) — Guidance for Industry, FDA, Rockville, MD, USA, 2023. Available at: https://www.fda.gov/media/127853/download (accessed June 11, 2025).
  29. U.S. Department of Health and Human Services (DHHS) and U.S. Food and Drug Administration (FDA): Premarket Tobacco Product Applications and Recordkeeping Requirements. Final Rule; FDA, Washington, DC, USA, 2021, 86 FR 55300–55439. Available at: https://www.govinfo.gov/content/pkg/FR-2021-10-05/pdf/2021-21011.pdf (accessed June 11, 2025)
  30. 30. Vansickel, A., S. Baxter, N. Sherwood, M. Kong, and L. Campbell: Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations; Nicotine Tob. Res. 24 (2022) 295–305. DOI: 10.1093/ntr/ntab183
    Vansickel A. Baxter S. Sherwood N. Kong M. Campbell L. Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations Nicotine Tob. Res. 24 2022 295 305 10.1093/ntr/ntab183
  31. 31. Henningfield J.E. and R.M. Keenan: Nicotine Delivery Kinetics and Abuse Liability; J. Consult. Clin. Psychol. 61 (1993) 743–750. DOI: 10.1037//0022-006x.61.5.743
    Henningfield J.E. Keenan R.M. Nicotine Delivery Kinetics and Abuse Liability J. Consult. Clin. Psychol. 61 1993 743 750 10.1037//0022-006x.61.5.743
  32. 32. Henningfield, J.E., D.K. Hatsukami, M. Zeller, and E. Peters: Conference on Abuse Liability and Appeal of Tobacco Products: Conclusions and Recommendations; Drug Alcohol Depend. 116 (2011) 1–7. DOI: 10.1016/j.drugalcdep.2010.12.009
    Henningfield J.E. Hatsukami D.K. Zeller M. Peters E. Conference on Abuse Liability and Appeal of Tobacco Products: Conclusions and Recommendations Drug Alcohol Depend. 116 2011 1 7 10.1016/j.drugalcdep.2010.12.009
  33. 33. Hatsukami, D.K., Y. Zhang, R.J. O’Connor, and H.H. Severson: Subjective Responses to Oral Tobacco Products: Scale Validation; Nicotine Tob. Res. 15 (2013) 1259–1264. DOI: 10.1093/ntr/nts265
    Hatsukami D.K. Zhang Y. O’Connor R.J. Severson H.H. Subjective Responses to Oral Tobacco Products: Scale Validation Nicotine Tob. Res. 15 2013 1259 1264 10.1093/ntr/nts265
  34. Vansickel A.R., C.O. Cobb, M.F. Weaver, and T.E. Eissenberg. A Clinical Laboratory Model for Evaluating the Acute Effects of Electronic “Cigarettes”: Nicotine Delivery Profile and Cardiovascular and Subjective Effects. Cancer Epidemiol. Biomarkers Prev. 19 (2010) 1945–1953. DOI: 10.1158/1055-9965.epi-10-0288.
  35. 35. Stiles, M.F., L.R. Campbell, D.W. Graff, B.A. Jones, R.V. Fant, and J.E. Henningfield: Pharmacodynamic and Pharmacokinetic Assessment of Electronic Cigarettes, Combustible Cigarettes, and Nicotine Gum: Implications for Abuse Liability; Psychopharmacology 234 (2017) 2643–2655. DOI: 10.1007/s00213-017-4665-y
    Stiles M.F. Campbell L.R. Graff D.W. Jones B.A. Fant R.V. Henningfield J.E. Pharmacodynamic and Pharmacokinetic Assessment of Electronic Cigarettes, Combustible Cigarettes, and Nicotine Gum: Implications for Abuse Liability Psychopharmacology 234 2017 2643 2655 10.1007/s00213-017-4665-y
  36. 36. Fearon I.M., A.C. Eldridge, N. Gal, M. McEwan, M.F. Stiles, E.K. Round. Nicotine Pharmacokinetics of Electronic Cigarettes: A Review of the Literature; Regul. Toxicol. Pharmacol. 100 (2018) 25–34. DOI: 10.1016/j.yrtph.2018.09.004
    Fearon I.M. Eldridge A.C. Gal N. McEwan M. Stiles M.F. Round E.K. Nicotine Pharmacokinetics of Electronic Cigarettes: A Review of the Literature Regul. Toxicol. Pharmacol. 100 2018 25 34 10.1016/j.yrtph.2018.09.004
  37. 37. Stiles, M.F., L.R. Campbell, T. Jin, D.W. Graff, R.V. Fant, and J.E. Henningfield: Assessment of the Abuse Liability of Three Menthol Vuse Solo Electronic Cigarettes Relative to Combustible Cigarettes and Nicotine Gum; Psychopharmacology 235 (2018) 2077–2086. DOI: 10.1007/s00213-018-4904-x
    Stiles M.F. Campbell L.R. Jin T. Graff D.W. Fant R.V. Henningfield J.E. Assessment of the Abuse Liability of Three Menthol Vuse Solo Electronic Cigarettes Relative to Combustible Cigarettes and Nicotine Gum Psychopharmacology 235 2018 2077 2086 10.1007/s00213-018-4904-x
  38. 38. Maloney, S.F., A. Breland, E.K. Soule, M. Hiler, C. Ramôa, T. Lipato, and T. Eissenberg: Abuse Liability Assessment of an Electronic Cigarette in Combustible Cigarette Smokers; Exp. Clin. Psychopharmacol. 27 (2019) 443–454. DOI: 10.1037/pha0000261
    Maloney S.F. Breland A. Soule E.K. Hiler M. Ramôa C. Lipato T. Eissenberg T. Abuse Liability Assessment of an Electronic Cigarette in Combustible Cigarette Smokers Exp. Clin. Psychopharmacol. 27 2019 443 454 10.1037/pha0000261
  39. 39. Ebajemito, J.K., M. McEwan, N. Gale, O.M. Camacho, G. Hardie, and C.J. Proctor: A Randomised Controlled Single-Centre Open-Label Pharmacokinetic Study to Examine Various Approaches of Nicotine Delivery Using Electronic Cigarettes. Sci. Rep. 10 (2020) 19980. DOI: 10.1038/s41598-020-76610-4
    Ebajemito J.K. McEwan M. Gale N. Camacho O.M. Hardie G. Proctor C.J. A Randomised Controlled Single-Centre Open-Label Pharmacokinetic Study to Examine Various Approaches of Nicotine Delivery Using Electronic Cigarettes Sci. Rep. 10 2020 19980 10.1038/s41598-020-76610-4
  40. 40. Goldenson N.I., A.R. Buchhalter, E.M. Augustson, M.L. Rubinstein, and J.E. Henningfield: Abuse Liability Assessment of the JUUL System in Four Flavors Relative to Combustible Cigarette, Nicotine Gum and a Comparator Electronic Nicotine Delivery System among Adult Smokers; Drug Alcohol Depend. 217 (2020) 108395. DOI: 10.1016/j.drugalcdep.2020.108395
    Goldenson N.I. Buchhalter A.R. Augustson E.M. Rubinstein M.L. Henningfield J.E. Abuse Liability Assessment of the JUUL System in Four Flavors Relative to Combustible Cigarette, Nicotine Gum and a Comparator Electronic Nicotine Delivery System among Adult Smokers Drug Alcohol Depend. 217 2020 108395 10.1016/j.drugalcdep.2020.108395
  41. 41. Goldenson N.I., A.R. Buchhalter, E.M. Augustson, M.L. Rubinstein, D. Van Hoof, and J.E. Henningfield: Abuse Liability Assessment of the JUUL System in Two Nicotine Concentrations Compared to Combustible Cigarette, Nicotine Gum and Comparator Electronic Nicotine Delivery System; Drug Alcohol Depend. 217 (2020) 108441. DOI: 10.1016/j.drugalcdep.2020.108441
    Goldenson N.I. Buchhalter A.R. Augustson E.M. Rubinstein M.L. Van Hoof D. Henningfield J.E. Abuse Liability Assessment of the JUUL System in Two Nicotine Concentrations Compared to Combustible Cigarette, Nicotine Gum and Comparator Electronic Nicotine Delivery System Drug Alcohol Depend. 217 2020 108441 10.1016/j.drugalcdep.2020.108441
  42. 42. Hajek, P., K. Pittaccio, F. Pesola, K. Myers Smith, A. Phillips-Waller, and D. Przulj: Nicotine Delivery and Users’ Reactions to Juul Compared with Cigarettes and Other E-Cigarette Products; Addiction 115 (2020) 1141–1148. DOI: 10.1111/add.14936
    Hajek P. Pittaccio K. Pesola F. Myers Smith K. Phillips-Waller A. Przulj D. Nicotine Delivery and Users’ Reactions to Juul Compared with Cigarettes and Other E-Cigarette Products Addiction 115 2020 1141 1148 10.1111/add.14936
  43. 43. Goldenson N.I., I.M. Fearon, A.R. Buchhalter, and J.E. Henningfield: An Open-Label, Randomized, Controlled, Crossover Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in Adult Smokers; Nicotine Tob. Res. 23 (2021) 947–955. DOI: 10.1093/ntr/ntab001
    Goldenson N.I. Fearon I.M. Buchhalter A.R. Henningfield J.E. An Open-Label, Randomized, Controlled, Crossover Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in Adult Smokers Nicotine Tob. Res. 23 2021 947 955 10.1093/ntr/ntab001
  44. 44. Campbell, C., T. Jin, E.K. Round, E. Schmidt, P. Nelson, and S. Baxter: Part One: Abuse Liability of Vuse Solo (G2) Electronic Nicotine Delivery System Relative to Combustible Cigarettes and Nicotine Gum; Sci. Rep. 12 (2022) 22080. DOI: 10.1038/s41598-022-26417-2
    Campbell C. Jin T. Round E.K. Schmidt E. Nelson P. Baxter S. Part One: Abuse Liability of Vuse Solo (G2) Electronic Nicotine Delivery System Relative to Combustible Cigarettes and Nicotine Gum Sci. Rep. 12 2022 22080 10.1038/s41598-022-26417-2
  45. 45. Benowitz, N.L., G.E. Swan, P. Jacob III, C.N Lessov-Schlaggar., and R.F. Tyndale: CYP2A6 Genotype and the Metabolism and Disposition Kinetics of Nicotine; Clin. Pharmacol. Ther. 80 (2006) 457–467. DOI: 10.1016/j.clpt.2006.08.011
    Benowitz N.L. Swan G.E. Jacob P. III Lessov-Schlaggar C.N. Tyndale R.F. CYP2A6 Genotype and the Metabolism and Disposition Kinetics of Nicotine Clin. Pharmacol. Ther. 80 2006 457 467 10.1016/j.clpt.2006.08.011
  46. 46. Shiffman, S., E.J. Cone, A.R. Buchhalter, J.E. Henningfield, J.M. Rohay, J.G. Gitchell, J.M. Pinney, and T. Chau: Rapid Absorption of Nicotine from New Nicotine Gum Formulations; Pharmacol. Biochem. Behav. 91 (2009) 380–384. DOI: 10.1016/j.pbb.2008.08.012
    Shiffman S. Cone E.J. Buchhalter A.R. Henningfield J.E. Rohay J.M. Gitchell J.G. Pinney J.M. Chau T. Rapid Absorption of Nicotine from New Nicotine Gum Formulations Pharmacol. Biochem. Behav. 91 2009 380 384 10.1016/j.pbb.2008.08.012
  47. Han, L.: Calculating the Point Estimate and Confidence Interval of Hodges Lehmann’s Median Using SAS® Software; SESUG Proceedings (2008) Paper ST-154. Available at: https://analytics.ncsu.edu/sesug/2008/ST-154.pdf (accessed June 11, 2025)
  48. Daniel, W.W.: Applied Nonparametric Statistics, 2nd ed., PWS-KENT, Boston, MA, USA, 1990, 635 pp., ISBN: 9780534381943.
  49. 49. Gades, M.S., A. Petersen, E. Meier, B.R. Lindgren, R.J. O’Connor, P.G. Shields, and D. Hatsukami: The Role of Subjective Responses in Electronic Cigarette Uptake and Substitution in Adult Smokers. Drug Alcohol Depend. 212 (2020) 107999. DOI: 10.1016/j.drugalcdep.2020.107999
    Gades M.S. Petersen A. Meier E. Lindgren B.R. O’Connor R.J. Shields P.G. Hatsukami D. The Role of Subjective Responses in Electronic Cigarette Uptake and Substitution in Adult Smokers Drug Alcohol Depend 212 2020 107999 10.1016/j.drugalcdep.2020.107999
  50. 50. Goldenson N.I., E.M. Augustson, J. Chen, and S. Shiffman: Pharmacokinetic and Subjective Assessment of Prototype Juul2 Electronic Nicotine Delivery System in Two Nicotine Concentrations, JUUL System, IQOS, and Combustible Cigarette; Psychopharmacology 239 (2022) 977–988. DOI: 10.1007/s00213-022-06100-0
    Goldenson N.I. Augustson E.M. Chen J. Shiffman S. Pharmacokinetic and Subjective Assessment of Prototype Juul2 Electronic Nicotine Delivery System in Two Nicotine Concentrations, JUUL System, IQOS, and Combustible Cigarette Psychopharmacology 239 2022 977 988 10.1007/s00213-022-06100-0
  51. 51. Ashley, D.L., C.A. Spears, S.R. Weaver, J. Huang, and M.P. Eriksen: E-Cigarettes: How Can They Help Smokers Quit Without Addicting a New Generation?; Prev. Med. 140 (2020) 106145. DOI: 10.1016/j.ypmed.2020.106145
    Ashley D.L. Spears C.A. Weaver S.R. Huang J. Eriksen M.P. E-Cigarettes: How Can They Help Smokers Quit Without Addicting a New Generation? Prev. Med. 140 2020 106145 10.1016/j.ypmed.2020.106145
  52. 52. Cahn, Z., J. Drope, C.E. Douglas, R. Henson, C.J. Berg, D.L. Ashley, and M.P. Eriksen: Applying the Population Health Standard to the Regulation of Electronic Nicotine Delivery Systems; Nicotine Tob. Res. 23 (2021) 780–789. DOI: 10.1093/ntr/ntaa190
    Cahn Z. Drope J. Douglas C.E. Henson R. Berg C.J. Ashley D.L. Eriksen M.P. Applying the Population Health Standard to the Regulation of Electronic Nicotine Delivery Systems Nicotine Tob. Res. 23 2021 780 789 10.1093/ntr/ntaa190
  53. 53. Goldenson N.I., Y. Ding, S. Prakash, C. Hatcher, E.M. Augustson, and S. Shiffman: Differences in Switching Away from Smoking among Adult Smokers Using JUUL Products in Regions with Different Maximum Nicotine Concentrations: North America and the United Kingdom; Nicotine Tob. Res. 23 (2021) 1821–1830. DOI: 10.1093/ntr/ntab062
    Goldenson N.I. Ding Y. Prakash S. Hatcher C. Augustson E.M. Shiffman S. Differences in Switching Away from Smoking among Adult Smokers Using JUUL Products in Regions with Different Maximum Nicotine Concentrations: North America and the United Kingdom Nicotine Tob. Res. 23 2021 1821 1830 10.1093/ntr/ntab062
  54. U.S. Food and Drug Administration (FDA): Technical Project Lead (TPL) Review of PMTAs: Vuse Solo, 2021. Available at: https://www.fda.gov/media/153017/download (accessed June 11, 2025)
  55. 55. Prakash, S., C. Hatcher, and S. Shiffman: Prevalence of ENDS and JUUL Use, by Smoking Status, in National Samples of Young Adults and Older Adults in the U.S.; Am. J. Health Behav. 45 (2021) 402–418. DOI: 10.5993/AJHB.45.3.2
    Prakash S. Hatcher C. Shiffman S. Prevalence of ENDS and JUUL Use, by Smoking Status, in National Samples of Young Adults and Older Adults in the U.S. Am. J. Health Behav. 45 2021 402 418 10.5993/AJHB.45.3.2
  56. 56. Krishnan, N., L.C. Abroms, and C.J. Berg: Electronic Nicotine Product Cessation and Cigarette Smoking: Analysis of Waves 3 and 4 from the PATH Study; Nicotine Tob. Res. 24 (2021) 324–332. DOI: 10.1093/ntr/ntab155
    Krishnan N. Abroms L.C. Berg C.J. Electronic Nicotine Product Cessation and Cigarette Smoking: Analysis of Waves 3 and 4 from the PATH Study Nicotine Tob. Res. 24 2021 324 332 10.1093/ntr/ntab155
  57. 57. Hajek, P., M.L. Goniewicz, A. Phillips, K. Myers Smith, O. West, and H. McRobbie: Nicotine Intake from Electronic Cigarettes on Initial Use and after 4 Weeks of Regular Use; Nicotine Tob. Res. 17 (2015) 175–179. DOI: 10.1093/ntr/ntu153
    Hajek P. Goniewicz M.L. Phillips A. Myers Smith K. West O. McRobbie H. Nicotine Intake from Electronic Cigarettes on Initial Use and after 4 Weeks of Regular Use Nicotine Tob. Res. 17 2015 175 179 10.1093/ntr/ntu153
  58. 58.Farsalinos, K.E., A. Spyrou, C. Stefopoulos, K. Tsimopoulou, P. Kourkoveli, D. Tsiapras, S. Kyrzopoulos, K. Poulas, and V. Voudris: Nicotine Absorption from Electronic Cigarette Use: Comparison Between Experienced Consumers (Vapers) and Naïve Users (Smokers); Sci. Rep. 5 (2015) 11269. DOI: 10.1038/srep11269
    Farsalinos K.E. Spyrou A. Stefopoulos C. Tsimopoulou K. Kourkoveli P. Tsiapras D. Kyrzopoulos S. Poulas K. Voudris V. Nicotine Absorption from Electronic Cigarette Use: Comparison Between Experienced Consumers (Vapers) and Naïve Users (Smokers) Sci. Rep. 5 2015 11269 10.1038/srep11269
Language: English
Page range: 117 - 134
Submitted on: Jan 9, 2025
Accepted on: May 13, 2025
Published on: Jul 22, 2025
Published by: Institut für Tabakforschung GmbH
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Donald W. Graff, Ian M. Fearon, Mark McClean, Rebeca Melara, Ramadevi Vemuri, Catherine Mills, published by Institut für Tabakforschung GmbH
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.